Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00316849
What this trial is testing

Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT00003996
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 93
Early research (Phase 1)Study completedNCT01849146
What this trial is testing

Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
GlioblastomaRecurrent Glioblastoma
National Cancer Institute (NCI) 74
Not applicableLooking for participantsNCT05839379
What this trial is testing

Targeted Pediatric High-Grade Glioma Therapy

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine GliomaAnaplastic Astrocytoma+6 more
Nationwide Children's Hospital 350
Early research (Phase 1)Active Not RecruitingNCT05739942
What this trial is testing

Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma

Who this might be right for
Newly Diagnosed and Recurrent Glioblastoma
Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Study completedNCT01790503
What this trial is testing

A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Patients With Newly Diagnosed Glioblastoma
Daiichi Sankyo 65
Not applicableUnknownNCT03869242
What this trial is testing

NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM

Who this might be right for
Glioblastoma
Tel-Aviv Sourasky Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06595186
What this trial is testing

JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme (GBM)
JenKem Technology Co., Ltd. 25
Large-scale testing (Phase 3)WithdrawnNCT04105374
What this trial is testing

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

Who this might be right for
Anaplastic AstrocytomaGlioblastomaOligodendroglioma+1 more
NRG Oncology
Testing effectiveness (Phase 2)Looking for participantsNCT04443010
What this trial is testing

Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Philogen S.p.A. 226
Early research (Phase 1)Ended earlyNCT02880410
What this trial is testing

Feasibility Study on LITT for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Monteris Medical 3
Testing effectiveness (Phase 2)Study completedNCT00042991
What this trial is testing

Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas

Who this might be right for
Untreated Childhood Anaplastic AstrocytomaUntreated Childhood Anaplastic OligodendrogliomaUntreated Childhood Brain Stem Glioma+5 more
National Cancer Institute (NCI) 69
Early research (Phase 1)WithdrawnNCT00703859
What this trial is testing

Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
AHS Cancer Control Alberta
Early research (Phase 1)Study completedNCT00045565
What this trial is testing

Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03919071
What this trial is testing

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic Astrocytoma, Not Otherwise SpecifiedAnaplastic Ganglioglioma+5 more
National Cancer Institute (NCI) 58
Large-scale testing (Phase 3)Study completedNCT03345095
What this trial is testing

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Newly Diagnosed Glioblastoma
European Organisation for Research and Treatment of Cancer - EORTC 749
Early research (Phase 1)Not Yet RecruitingNCT07422896
What this trial is testing

A Phase I First-in-human Trial of Bvax (B-cell Vaccination) in Addition to Standard of Care Chemoradiotherapy for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Catalina Lee Chang 25
Testing effectiveness (Phase 2)Study completedNCT00974987
What this trial is testing

Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 32
Testing effectiveness (Phase 2)Ended earlyNCT04421378
What this trial is testing

Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Karyopharm Therapeutics Inc 74
Early research (Phase 1)WithdrawnNCT00904852
What this trial is testing

Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Millennium Pharmaceuticals, Inc. 30
Next Page